台湾2011-2017年血流感染中氟康唑不敏感热带念珠菌的克隆性分析
本研究对344例首次热带念珠菌血流感染患者的分离株进行分析,发现58例(16.9%)感染氟康唑不敏感(FNS)热带念珠菌,且对伊曲康唑、伏立康唑和泊沙康唑交叉耐药,其中55.2%(32/58)患者无唑类用药史。多位点序列分型显示FNS分离株遗传高度相关,但无时间或地域聚集;识别出DST225等型别与台湾水果及北京、上海医院报道的型别一致,提示FNS热带念珠菌跨境传播,需加强临床分离株主动监测。
要点
- 16.9%热带念珠菌血流感染为氟康唑不敏感且交叉唑类耐药
- 55.2%FNS感染患者无既往唑类暴露史
- FNS分离株遗传相关但无时间地域聚集,提示跨境传播
核心结论
- FNS热带念珠菌血流感染占16.9%,且对多种唑类交叉耐药,遗传相关但无本地聚集,提示跨境传播。
研究设计与样本
- 对344例首次热带念珠菌血流感染患者的分离株进行回顾性分析,采用多位点序列分型。
主要发现
- 58例(16.9%)患者感染FNS热带念珠菌,对伊曲康唑、伏立康唑和泊沙康唑交叉耐药。
- 55.2%(32/58)FNS感染患者无唑类用药史。
- FNS分离株遗传高度相关,但无时间或地域聚集。
- DST225曾报道于台湾水果及北京医院,DST376和DST505-7曾报道于上海医院。
临床怎么用
- 对热带念珠菌血流感染应关注氟康唑不敏感可能,尤其无唑类暴露史者。
- 建议加强临床分离株主动监测以发现FNS热带念珠菌传播。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Candida tropicalis is the leading cause of non-C. albicans candidemia in tropical Asia and Latin America. We evaluated isolates from 344 patients with an initial episode of C. tropicalis candidemia. We found that 58 (16.9%) patients were infected by fluconazole-nonsusceptible (FNS) C. tropicalis with cross resistance to itraconazole, voriconazole, and posaconazole; 55.2% (32/58) of patients were azole-naive. Multilocus sequence typing analysis revealed FNS isolates were genetically closely related, but we did not see time- or place-clustering. Among the diploid sequence types (DSTs), we noted DST225, which has been reported from fruit in Taiwan and hospitals in Beijing, China, as well as DST376 and DST505-7, which also were reported from hospitals in Shanghai, China. Our findings suggest cross-boundary expansion of FNS C. tropicalis and highlight the importance of active surveillance of clinical isolates to detect dissemination of this pathogen and explore potential sources in the community.
引用
- Chen PY, Chuang YC, Wu UI, et al. Clonality of Fluconazole-Nonsusceptible Candida tropicalis in Bloodstream Infections, Taiwan, 2011-2017. Emerg Infect Dis. 2019. PMID: 31441426. doi:10.3201/eid2509.190520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。